ARC Clinical Fellowship Program

The Amyloidosis Research Consortium (ARC) Clinical Fellowship Program provides funding for up to eight one-year fellowships at established amyloidosis centers across the U.S., training promising MD fellowship applicants in the diagnosis and management of amyloidosis, multidisciplinary collaboration, research participation, and health equity; each fellow is mentored by established field leaders. FIA: launched Oct 2024 (announcement page); specific deadline, stipend amount, and current-cycle status were not on the scraped pages (amount/deadline left null). Excluded from extraction: the 2018 Pfizer Global ASPIRE grants (third-party/Pfizer program), the Prothena/Sanguine at-home study, ARC's NIH R13 conference award (ARC is the recipient), and ARC's sponsorship opportunities (industry funds ARC, not applicant grants). FLAG for re-scrape of the Professionals → HCP Education → Clinical Fellowship page.